Our research findings indicate that SLC16A1 acts as an oncogene in HNSCC, and that abnormally high expression of SLC16A1 significantly accelerates the development and progression of HNSCC by conferring resistance to ferroptosis. The gene discussed is SLC16A1; the disease is head and neck squamous cell carcinoma.